Does MedTech vulnerability scanning shift risk or solve it?

AdvancedUNO
13 Jun, 2026
Does MedTech vulnerability scanning shift risk or solve it?

8 min read

An Operational Balance Sheet

  • The core process: Systematically identifying, classifying, and assessing software and hardware flaws within connected clinical devices, such as the 11 vulnerabilities recently exposed in GE Healthcare Vivid T9 ultrasound systems.
  • Why it matters: Unpatched medical devices are active entry points; the recent disruption at Stryker Corp. demonstrates that a single active breach can cripple an entire global Microsoft environment.
  • The hidden cost: Scanning alone does not fix code; it merely generates a massive backlog of unpatched vulnerabilities that clinical engineering teams must manually triage.

Why MedTech vulnerability scanning costs hospitals more than manufacturers

When security researchers expose 11 vulnerabilities in a clinical ultrasound device, the financial clock starts ticking for the hospital, not the vendor. In May 2024, when Nozomi Networks Labs disclosed a suite of flaws in GE Healthcare Vivid T9 ultrasound systems, clinical engineering departments across the globe had to scramble. The physical machines, which run a customized version of Microsoft Windows 10, are typical of modern healthcare infrastructure: highly specialized clinical tools wrapped in standard consumer operating systems that are difficult to patch without voiding regulatory approvals.

This dynamic exposes a fundamental economic imbalance in healthcare cybersecurity. Medical device manufacturers capture high-margin revenue when they sell connected hardware, yet they routinely transfer the long-term operational costs of vulnerability management to the healthcare delivery organizations that buy them. When a vulnerability is found, the manufacturer issues an advisory; the hospital, however, must dedicate clinical engineers to locate the physical machine, take it out of service, test the patch in a non-production environment, and manually apply the update. If the device is running a legacy operating system that the manufacturer no longer actively supports, the hospital must design, implement, and maintain expensive network segmentation controls to isolate the threat.

A medical device with unpatched firmware is like a leased commercial vehicle with a known brake defect: the manufacturer acknowledges the recall, but the fleet operator loses daily revenue while the truck sits in the service bay. This cost shift is particularly acute during active security incidents. For instance, the suspected Iran-linked cyberattack on Stryker Corp. in March 2026, claimed by the Handala hacking group, disrupted global Microsoft environments and knocked internal services offline. When these enterprise-wide disruptions occur, hospitals are forced to restrict access to critical information systems, absorbing the compounding costs of clinical downtime, diverted patients, and emergency incident response while the original entry points remain unaddressed.

Weighing the friction of active labs against passive clinical scans

To manage this risk, hospital security leaders are caught between two valid but highly friction-intensive operational strategies: active sandbox testing in dedicated physical labs, or continuous passive network monitoring across the live clinical environment. Each approach has distinct financial trade-offs, and neither offers a complete solution on its own.

The first approach relies on dedicated physical testing environments to validate security controls before devices ever touch a patient. This model has gained traction with initiatives like the 4,500-square-foot ConnectSafe cyber facility launched by Deloitte India in 2026, which simulates real-world threat scenarios across operational technologies without disrupting live hospital operations. Similarly, Indiana University Health collaborated with TRIMEDX to build a dedicated medical device security lab aimed at testing devices during the procurement and development phases. These labs allow engineers to perform aggressive, active vulnerability scans, inspect firmware, and test exploit scenarios that would crash a device in an active operating room.

The second approach relies on continuous passive network monitoring. Using specialized tools from vendors like Nozomi Networks, Claroty, or Ordr, hospitals analyze network traffic to identify connected medical devices by their communication protocols. This method avoids the risk of crashing sensitive clinical equipment with active network scans. It provides immediate, hospital-wide visibility into what devices are connected, what protocols they are using, and whether they are communicating with unauthorized external servers.

The hidden friction of passive scanning alerts

While passive monitoring is easier to deploy, it introduces a massive operational burden in the form of alert fatigue. Passive scanners identify thousands of potential vulnerabilities based on software bills of materials (SBOMs) and network signatures, but they cannot verify if those vulnerabilities are actually exploitable in the hospital's specific network configuration. The hospital's security team is left with a mountain of data and no clear path to remediation, turning a technical tool into an administrative bottleneck.

"A vulnerability scan is not a security cure; it is merely a diagnostic test that tells you how sick your network is, without offering a prescription."

To compare these two operational strategies, we can evaluate their financial and technical trade-offs across several key metrics:

Operational Metric Active Lab Sandboxing (Deloitte ConnectSafe / TRIMEDX Model) Passive Network Monitoring (Nozomi / Claroty Model)
Upfront Capital Cost High (Requires physical space, test devices, and specialized lab equipment) Moderate (Software licensing and network tap installations)
Operational Friction High (Requires manual testing by specialized clinical engineers) Low to Moderate (Automated data collection, but high alert volume)
Clinical Risk during Scan Zero (Devices are completely isolated from live patient networks) Zero (Passive sniffing does not inject traffic into devices)
Remediation Accuracy Very High (Exploits are verified and patches are validated in-house) Low (Identifies potential vulnerabilities but cannot confirm exploitability)
Scalability Poor (Limited by physical lab throughput and device availability) Excellent (Monitors thousands of connected devices simultaneously)

How unpatched operating systems quietly drain hospital operational margins

The financial reality of medical device vulnerability management is best understood through a gritty, real-world scenario. Consider a representative 350-bed regional hospital system operating a fleet of 45 legacy ultrasound units. These units run a customized, locked-down version of Windows 10, where the user interface prevents clinical staff from accessing the underlying operating system. However, the system still runs an accessory management web application and clinical software packages that contain unpatched vulnerabilities.

  1. The Discovery Phase: A passive network scanner flags a critical remote code execution vulnerability in the ultrasound's web application. Because the device is on a flat clinical network, the vulnerability puts the entire local network at risk. The security team must now verify if the flaw is real or a false positive.
  2. The Triage Phase: Because the hospital lacks a dedicated testing lab, clinical engineers must pull a working ultrasound unit out of the active clinical schedule. This manual coordination takes three hours of staff time and cancels four scheduled patient scans, costing the hospital approximately $2,400 in lost clinical revenue for that single afternoon.
  3. The Remediation Phase: The engineer discovers that the manufacturer's official patch requires a manual USB installation and a firmware update. The update fails on three of the oldest units due to hardware compatibility issues, forcing the IT security team to design custom micro-segmentation rules on their network firewalls. This process takes another twelve hours of engineering labor, quietly draining the hospital's operational budget to fix a software defect they did not create.

Rule of Thumb: If a medical device requires more than four hours of clinical downtime to patch a single CVE, the vulnerability is not a technical bug—it is an ongoing operational tax on your hospital's bottom line.

Where passive scanning actually holds up

Despite these operational challenges, passive network scanning remains highly effective in specific clinical scenarios. For high-volume, highly fragmented networks with thousands of low-risk Internet of Medical Things (IoMT) devices—such as smart infusion pumps, patient monitors, and temperature sensors—active lab testing is physically and financially impossible. You cannot bring five thousand infusion pumps into a physical lab to test every minor software update.

In these environments, passive scanning is the only practical way to build an accurate, real-time asset inventory. It allows security teams to detect anomalous behavior, such as an infusion pump suddenly trying to communicate with an external server or using an unusual network protocol. While passive scanning does not fix the underlying software vulnerabilities, it gives hospitals the visibility they need to implement basic network defenses, such as isolating compromised devices before a threat can spread across the entire clinical network.

Frequently Asked Questions

What happens to our liability when a passive scan flags a critical CVE on a life-support device, but the manufacturer has not released a patch?

The hospital inherits the operational and legal liability the moment the vulnerability is identified on their network. Under Joint Commission standards and HIPAA security rules, hospitals must document a formal risk-mitigation plan. If no patch exists, the hospital must implement compensating controls, such as strict network segmentation or access control lists, to isolate the device's network traffic until the manufacturer releases a validated update.

How do we handle clinical network segmentation when a legacy imaging system runs on an unsupported, customized Windows 10 build?

You must isolate the device using a virtual local area network (VLAN) combined with micro-segmentation firewalls. This configuration restricts the imaging system's communication to only the specific PACS (Picture Archiving and Communication System) servers and workstations it needs to function, blocking all other internal and external network traffic to prevent lateral movement during a breach.

Why can't we run traditional active IT vulnerability scanners like Nessus on active clinical networks?

Traditional active scanners send aggressive, unexpected network packets to identify open ports and services. While standard IT servers can handle this traffic, sensitive medical devices like patient monitors or anesthesia machines often have fragile network stacks. Active scans can easily overwhelm these devices, causing them to lock up, reboot, or fail entirely while actively connected to a patient.

If a vendor provides a Software Bill of Materials (SBOM), does that eliminate the need for physical lab testing?

No. An SBOM is simply a list of ingredients; it does not tell you how those ingredients interact under stress. While tools like MedCrypt's SaaS platform use SBOMs to benchmark security and quantify risk in monetary terms, physical lab testing is still required to verify whether a vulnerability in a third-party software component can actually be exploited in the device's real-world clinical configuration.

The Final Verdict: The choice between physical lab testing and passive scanning is not about finding the "better" security tool; it is about deciding where your hospital can afford to spend its limited resources. Until medical device manufacturers are held financially responsible for the long-term security of their products, hospitals must treat vulnerability scanning as a practical risk-management exercise rather than a simple technical fix.

References & Further Reading

  • Deloitte India ConnectSafe™ Launch: Detailed in reporting by Digital Health News (March 31, 2026), highlighting the role of the 4,500 sq ft facility in testing threat scenarios for operational technologies and MedTech systems.
  • GE Healthcare Vivid T9 Vulnerabilities: Disclosed by GE Healthcare and analyzed by Nozomi Networks Labs (May 15, 2024), detailing 11 vulnerabilities in ultrasound devices running customized Windows 10.
  • TRIMEDX and IU Health Lab Collaboration: Announced in Medical Design & Outsourcing (October 26, 2022), focusing on pre-procurement security testing for medical devices.
  • Stryker Corp. Cyberattack: Reported by Industrial Cyber (March 13, 2026), documenting the global network disruption claimed by the Handala persona.
  • MedCrypt SaaS Risk Assessment Platform: Introduced in Medical Device and Diagnostic Industry (June 11, 2025), discussing benchmarking security maturity and translating risk into financial metrics.

Related from this blog

Sources

Next Post Previous Post
No Comment
Add Comment
comment url